M11.9 identifies crystal arthropathy when the specific crystal type, joint site, or both are not documented in the medical record.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 14
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M11.9.
Source · Editorial brief grounded in 5 cited references ↓
- Document the crystal type whenever known — CPPD, hydroxyapatite (BCP), or calcium oxalate — to support a more specific M11 subcategory rather than defaulting to M11.9.
- Record the specific joint affected (knee, wrist, shoulder, ankle, etc.) and laterality (right or left); this detail enables a more precise code and reduces audit exposure.
- Note the diagnostic method used — polarized light microscopy of synovial fluid, radiographic chondrocalcinosis, or CT findings — to substantiate the crystal arthropathy diagnosis.
- If the encounter is based on an outside referral with only a generic 'crystal arthritis' label, document that the crystal type was not specified or identified at this visit to justify M11.9.
- Distinguish crystal arthropathy from gout explicitly in the note; gout (M1A/M10) is excluded from M11 and the wrong family will cause a claim mismatch.
Related CPT procedures
Procedure codes commonly billed with M11.9. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M11.9 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M11.9 when the provider documented CPPD or pseudogout — those cases belong in M11.8 (other specified crystal arthropathies), not the unspecified code.
- Confusing crystal arthropathy with gout and coding M11.9 instead of M10 or M1A; gout is explicitly excluded from the M11 category.
- Using M11.9 when the joint is documented but the coder did not escalate to the joint-specific M11.8x subcodes, leaving reimbursable specificity on the table.
- Failing to query the provider when synovial fluid analysis results are in the chart but the note does not name the crystal type — that result supports a more specific code.
- Applying M11.9 to a patient with documented chondrocalcinosis on imaging; that maps to M11.1 (familial) or M11.2 (other), not the unspecified code.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
Use M11.9 only when the provider documents crystal arthropathy but fails to specify the crystal type (e.g., calcium pyrophosphate, hydroxyapatite) or the affected joint. This is a true last-resort code — the M11 category offers more specific alternatives: M11.0 for hydroxyapatite deposition disease, M11.1 for familial chondrocalcinosis, M11.2 for other chondrocalcinosis, and M11.8 for other specified crystal arthropathies. If the crystal type is documented and the joint is named, you should not be landing on M11.9.
Crystal arthropathies arise when microcrystals accumulate in or around joint spaces, triggering an immune-mediated inflammatory response. The M11 category excludes gout (coded to M1A or M10 depending on chronicity and tophus status) — gout's monosodium urate crystals have their own code family. Non-gout crystal arthropathies in M11 include CPPD (pseudogout), hydroxyapatite deposition disease, and rarer crystal types. Acute CPP crystal arthritis most commonly affects the knee, wrist, or shoulder in patients over 65. Joint aspiration with crystal analysis under polarized light microscopy is the diagnostic gold standard.
M11.9 maps to MS-DRG 553 (Bone diseases and arthropathies with MCC) and MS-DRG 554 (without MCC) for inpatient encounters. Because it carries no laterality and no crystal-type specificity, payers may flag it as underdocumented when a more specific M11 subcategory was available. Reserve it for genuinely ambiguous presentations — for example, when a patient is referred with an outside diagnosis of 'crystal arthritis' and the source crystal type has not been identified at your encounter.
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01When is M11.9 the correct code instead of a more specific M11 subcategory?
02Is gout coded under M11.9?
03Can M11.9 be used for CPPD or pseudogout?
04What MS-DRGs does M11.9 map to for inpatient billing?
05Does M11.9 require a laterality character?
06What CPT procedures are commonly billed alongside M11.9?
07Should a coder query the provider before assigning M11.9?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (FY2026, effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M11-/M11.9
- 03pmc.ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC6918617/
- 04unboundmedicine.comhttps://www.unboundmedicine.com/5minute/view/5-Minute-Clinical-Consult/816812/3.0/Crystal_Arthropathies
- 05aapc.comhttps://www.aapc.com/codes/icd-10-codes/M11
Mira AI Scribe
Mira's AI scribe captures the specific joint name, laterality, crystal type identified on synovial fluid analysis or imaging, and any prior diagnostic workup at the point of documentation — preventing the generic 'crystal arthritis' language that forces a coder to M11.9. When crystal type and joint site are both recorded, the encounter supports a more specific M11 subcategory, reducing audit risk and avoiding a payer query.
See how Mira captures M11.9 documentation